VeliKemalTopkaraMD

Adult Congenital Heart Disease, Heart Failure & Transplantation

Physician

Dr. Topkara is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
600 Highland Ave
Madison, WI 53792
Phone+1 608-263-1690

Fax+1 608-265-1918

New York Presbyterian Hospital (Columbia Campus)Fellowship, Advanced Heart Failure and Transplant Cardiology, 2013 - 2014
Washington University/B-JH/SLCH ConsortiumFellowship, Cardiovascular Disease, 2009 - 2013
Baylor College of MedicineResidency, Internal Medicine, 2006 - 2009
Sidney Kimmel Medical College at Thomas Jefferson UniversityInternship, Transitional Year, 2005 - 2006
Hacettepe University FOMClass of 2003

NY State Medical License 2013 - 2026
WI State Medical License 2024 - 2025
MO State Medical License Active through 2013
PA State Medical License 2005 - 2006
American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
American Board of Internal Medicine Cardiovascular Disease

PubMed

PET/CT with Myocardial Blood Flow Assessment Is Prognostic of Cardiac Allograft Vasculopathy Progression and Clinical Outcomes.
Nikil Prasad, Erin Harris, Ersilia M DeFilippis, Gabriel Sayer, Margarita Chernovolenko
Journal of Nuclear Medicine. 2025-02-03
Validation of the HeartMate 3 survival risk score in a large left ventricular assist device center.
Cathrine M Moeller, Gal Rubinstein, Daniel Oren, Andrea Fernandez Valledor, Dor Lotan
The Journal of Thoracic and Cardiovascular Surgery. 2025-02-01
Evolving indications and management patterns in heart - kidney transplantation.
Frederick M Lang, Veli K Topkara
Current Opinion in Nephrology and Hypertension. 2025-01-01

Journal Articles

Trends in US Heart Transplant Waitlist Activity and Volume During the Coronavirus Disease 2019 (COVID-19) Pandemic
Lauren Sinnenberg, Nosheen Reza, Michelle M Kittleson, Veli K Topkara, Maryjane A Farr, JAMA Cardiology
VA‐ECMO for Cardiogenic Shock in the Contemporary Era of Heart Transplantation: Which Patients Should Be Urgently Transplanted?
Yoshifumi Naka, Maryjane A Farr, Koji Takeda, Paolo Colombo, Hiroo Takayama, Arthur R Garan, Veli K Topkara, Clinical Transplantation

Trends in US Heart Transplant Waitlist Activity and Volume During the Coronavirus Disease 2019 (COVID-19) PandemicJuly 2020
Trends in US Heart Transplant Waitlist Activity and Volume During the Coronavirus Disease 2019 (COVID-19) PandemicJuly 2020
Outcomes Associated with Mammalian Target of Rapamycin (mTOR) Inhibitors in Heart Transplant Recipients: A Meta-Analysis☆March 2018
Outcomes Associated with Mammalian Target of Rapamycin (mTOR) Inhibitors in Heart Transplant Recipients: A Meta-Analysis☆March 2018
Prognostic Impact of Pulmonary Artery Pulsatility Index (PAPi) in Patients with Advanced Heart Failure: Insights from the ESCAPE TrialMarch 2018
Join now to see all

LV Unloading and Myocardial Recovery : An Exciting Future in the Continuum of Remission to RecoveryMarch 30th, 2023
Myocardial Recovery in Patients Receiving Contemporary Left Ventricular Assist DevicesJune 2nd, 2016
International Genome-Wide Association Study Consortium Identifies Novel Loci Associated with Blood Pressure in Children and AdolescentsMarch 11th, 2016
Join now to see all

Role of RNA helicase Ddx5 in pathological cardiac remodelingUNIVERSITY OF WISCONSIN-MADISON2024–2028
Role of RNA helicase Ddx5 in pathological cardiac remodelingCOLUMBIA UNIVERSITY HEALTH SCIENCES2023–2028